Brief: Cynata Therapeutics Receives Firm Commitments For A$5.0 Million Placement
06/04/2023 02:23
April 6 (Reuters) - Cynata Therapeutics Ltd CYP.AX :
* RECEIVED FIRM COMMITMENTS FOR A A$5.0 MILLION PLACEMENT AT
AN
OFFER PRICE OF A$0.215 PER SHARE
* PROCEEDS TO FUND CO'S CLINICAL PROGRAM INCLUDING PROPOSED
PHASE
2 CLINICAL TRIAL IN ACUTE GRAFT-VERSUS-HOST DISEASE
* WILL OFFER ELIGIBLE SHAREHOLDERS OPPORTUNITY TO
PARTICIPATE IN
SHARE PURCHASE PLAN WHICH WILL BE CAPPED AT A$2.0M
Source text for Eikon: ID:nASXbfrRyd
Further company coverage: CYP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cynata Therapeutics
See all newsBrief: Cynata Therapeutics Says Firm Commitments Received To Raise Further A$550,000 Via Placement
Brief: Cynata Therapeutics Enters Consultancy Agreement With LIR Bio Advisory
Brief: Cynata Therapeutics Establishes Share Sale Facility For Unmarketable Parcel Holders
Brief: Cynata Therapeutics Terminates Of At-The-Market Subscription Deed
Brief: Cynata Therapeutics Posts FY2026 Loss From Ordinary Activities After Tax A$9.1 Million